Physical characterization of component particles included in dry powder inhalers. I. Strategy review and static characteristics

Journal of Pharmaceutical Sciences

Volumn 96, Issue 5, 2007, Pages 1282-1301

  Hickey, Anthony J ^a   Mansour, Heidi M ^a   Telko, Martin J ^a   Xu, Zhen ^a   Smyth, Hugh D C ^a,d   Mulder, Tako ^b   Mclean, Richard ^c   Langridge, John ^b   Papadopoulos, Dimitris ^c  

^a UNIVERSITY OF NORTH CAROLINA   (United States)

^b DMV Fonterra Excipients   (Germany)

^c PFIZER GLOBAL RESEARCH AND DEVELOPMENT   (United Kingdom)

^d UNIVERSITY OF NEW MEXICO   (United States)

Author keywords

Aerosols; Formulation; Physical characterization; Physicochemical; Preformulation; Pulmonary; Pulmonary drug delivery; Solid state; Surface chemistry; Thermodynamics

Indexed keywords

LACTOSE; RESPITOSE; SALBUTAMOL; UNCLASSIFIED DRUG;

AEROSOL; DRUG DELIVERY SYSTEM; DRUG FORMULATION; DRUG RESEARCH; DRUG STRUCTURE; DRY POWDER; DYNAMICS; INFORMATION PROCESSING; PARTICLE SIZE; REVIEW; SOLID STATE; SURFACE PROPERTY;

EID: 34249300511     PISSN: 00223549     EISSN: 15206017     Source Type: Journal    
DOI: 10.1002/jps.20916     Document Type: Article

References (178)

1. Crowder TM, Hickey AJ, Louey MD, Orr N. 2003. A guide to pharmaceutical particlulate science. Englewood, CO: Interpharm Press/IHS.
2. Hickey AJ, editor. 2004. Pharmaceutical inhalation aerosol technology, 2nd ed. New York, NY: Marcel Dekker, Inc. 603 p.
3. Dunbar CHA, Holzner P. 1998. Dispersion and characterization of pharmaceutical dry powder aerosols. KONA Powder Part 16:7-45.
4. Concessio NM, Hickey AJ. 1994. Assessment of micronized powders dispersed as aerosols. Pharm Tech 18(9) 88-98.
5. Rietema K. 1991. The dynamics of fine powders. London, UK: Elsevier Science Publishing Co., Inc.
6. Concessio NM, Oort MMV, Knowles M, Hickey AJ. 1999. Pharmaceutical dry powder aerosols: Correlation of powder properties with dose delivery and implications for pharmacodynamic effect. Pharm Res 16(6) 828-834.
7. Taylor MK, Ginsburg J, Hickey AJ, Gheyas F. 2000. Composite method to quantify powder flow as a screening method in early tablet or capsule formulation development. AAPS Pharm Sci Tech 1(3) Article 18.
8. Pillai RS, Yeates DB, Miller IF, Hickey AJ. 1998. Controlled dissolution from wax-coated aerosol particles in canine lungs. J Appl Physiol 84(2) 717-725.
9. Pillai RS, Yeates DB, Miller IF, Hickey AJ. 1994. Controlled release from condensation coated respirable aerosol particles. J Aerosol Sci 25:461-477.
10. Kim EH-J, Chen XD, Pearce D. 2005. Effect of surface composition on the flowability of industrial spray-dried dairy powders. Colloids Surf B Biointerfaces 46:182-187.
11. Hickey AJ, Jackson GV, Fildes FJT. 1988. Preparation and characterization of disodium fluorescein powders in association with lauric and capric acids. J Pharm Sci 77:804-809.
12. Gaiani C, Ehrhardt JJ, Scher J, Hardy JG, Desobry S, Banon S. 2006. Surface composition of dairy powders observed by X-ray photoelectron spectroscopy and effects on their rehydration properties. Colloids Surf B Biointerfaces 49:71-78.
13. Bugay D. 2001. Characterization of the solid-state: Spectroscopic techniques. Adv Drug Deliv Rev 48:43-65.
14. Shah B, Kakumanu VK, Bansal AK. 2006. Analytical techniques for quantification of amorphous/crystalline phases in pharmaceutical solids. J Pharm Sci 95:1641-1665.
15. Stephenson GA, Forbes RA, Reutzel-Edens SM. 2001. Characterization of the solid-state: Quantitative issues. Adv Drug Deliv Rev 48:67-90.
16. Taylor L, Zografi G. 1998. The quantitative analysis of crystallinity using FT-Raman spectroscopy. Pharm Res 15:755-761.
17. Fini G. 2004. Applications of Raman spectroscopy to pharmacy. J Raman Spectrosc 35:335-337.
18. Newman AW, Bryn SR. 2003. Solid-state analysis of the active pharmaceutical ingredient in drug products. Drug Discov Today 8:898-905.
19. Pinzaru SC, Pavel I, Leopold N, Kiefer W. 2004. Identification and characterization of pharmaceuticals using Raman and surface-enhanced Raman scattering. J Raman Spectrosc 35:338-346.
20. Mansour HM, Hickey AJ. 2007. Raman characterization of drug delivery systems and pulmonary inhalation aerosols, a mini review. AAPS PharmSci Tech Submitted.
21. Sasic S. 2007. Raman mapping of low-content API pharmaceutical formulations. I. Mapping of alprazolam in alprazolam/xanax tablets. Pharm Res 24:58-65.
22. Vehring R. 2005. Red-excitation dispersive Raman spectroscopy is a suitable technique for solid-state analysis of respirable pharmaceutical powders. Appl Spectrosc 59:286-292.
23. Vehring R, Aardahl C, Schweiger G, Davis E. 1998. The characterization of fine particles originating from an uncharged aerosol: Size dependence and detection limits for Raman analysis. J Aerosol Sci 29:1045-1061.
24. Chan H, Clark AR, Feeley J, Kuo M, Lehrman S, Pikal-Cleland K, Miller D, Vehring R, Lechuga-Ballesteros D. 2004. Physical stability of salmon calcitonin spray-dried powders for inhalation. J Pharm Sci 93:792-804.
25. Hickey AJ, Mansour HM, Telko MJ, Xu Z, Smyth HDC, Mulder T, McLean R, Langridge J, Papadopoulous D. 2007. Physical characterization of component particles included in dry powder inhalers: II. dynamic characteristics (invited paper). J Pharm Sci 96: Accepted, (in press).
26. Telko MJ, Hickey AJ. 2005. Dry powder inhaler formulation. Respir Care 50:1209-1227.
27. Steckel H, Markefka P, teWierik H, Kammelar R. 2006. Effect of milling and sieving on functionality of dry powder inhalation products. Int J Pharm 309:51-59.
28. Larhrib H, Zeng XM, Martin GP, Marriott C, Pritchard J. 1999. The use of different grades of lactose as a carrier for aerosolised salbutamol sulphate. Int J Pharm 191:1-14.
29. Larhrib H, Martin GP, Marriott C, Prime D. 2003. The influence of carrier and drug morphology on drug delivery from dry powder formulations. Int J Pharm 257:283-296.
30. Iida K, Hayakawa Y, Okamoto H, Danjo K, Luenberger H. 2004. Influence of storage humidity on the in vitro inhalation properties of salbutamol sulfate dry powder with surface covered lactose carrier. Chem Pharm Bull (Tokyo) 52:444-446.
31. Iida K, Inagaki Y, Todo H, Okamoto H, Danjo K, Luenberger H. 2004. Effects of surface processing of lactose carrier particles on dry powder inhalation properties of salbutamol sulfate. Chem Pharm Bull 52:938-942.
32. York P. 1983. Solid-state properties of powders in the formulation and processing of solid dosage forms. Int J Pharm 14:1-28.
33. Vippagunta SR, Brittain HG, Grant DJW. 2001. Crystalline solids. Adv Drug Deliv Rev 48:3-26.
34. Clas S-D. 2003. The importance of characterizing the crystal form of the drug substance during drug development. Curr Opin Drug Discov Dev 6:550-560.
35. Datta S, Grant DJW. 2004. Crystal structures of drugs: Advances in determination, prediction and engineering. Nature Rev Drug Discov 3:42-57.
36. Sheth AR, Grant DJW. 2005. Relationship between the structure and properties of pharmaceutical crystals. KONA 23:36-48.
37. Rodriguez-Spong B, Price CP, Jayasankar A, Matzger AJ, Rodriguez-Hornedo N. 2004. General principles of pharmaceutical solid polymorphism: A supramolecular perspective. Adv Drug Deliv Rev 56:241-274.
38. Singhal D, Curatolo W. 2004. Drug polymorphism and dosage form design: A practical perspective. Adv Drug Deliv Rev 56:335-347.
39. Giron D, Goldbronn C, Mutz M, Pfeffer S, Piechon P, Schwab P. 2002. Solid state characterization of pharmaceutical hydrates. J Therm Anal Calorimetry 68:453-465.
40. Hancock BC, Zografi G. 1997. Characteristics and significance of the amorphous state. J Pharm Sci 86:1-12.
41. Yu L. 2001. Amorphous pharmaceutical solids: Preparation, characterization and stabilization. Adv Drug Deliv Rev 48:27-42.
42. Kaushal AM, Gupta P, Bansal AK. 2004. Amorphous drug delivery systems: Molecular aspects, design, and performance. Crit Rev Ther Drug Carrier Syst 21:133-193.
43. Hilden LR, Morris KR. 2004. Physics of the amorphous solids. J Pharm Sci 93:3-12.
44. Stevenson CL, Bennett DB, Lechuga-Ballesteros D. 2005. Pharmaceutical liquid crystals: The relevance of partially ordered systems. J Pharm Sci 94:1861-1880.
45. Amato I. 2007. Aspirin's dose of structural insight. Chemical and Engineering News 85:27-28.
46. Vishweshwar P, McMahon JA, Oliveira M, Peterson ML, Zaworotko MJ. 2005. The predictably elusive form II of aspirin. J Am Chem Soc 127:16802-16803.
47. Bond AD, Boese R, Desiraju GR. 2006. On the polymorphism of aspirin: Crystalline aspirin as intergrowths of two "polymorphic domains". Angewandte Chemie International Ed In English 45; DOI:10.1002\anie.200603373.
48. Bond AD, Boese R, Desiraju GR. 2007. On the polymorphism of aspirin. Angewandte Chemie International Ed In English 45:615-617.
49. Wunderlich B. 1999. A classification of molecules, phases, and transitions as recognized by thermal analysis. Thermochimica Acta 340-341:37-52.
50. Bates S, Zografi G, Engers D, Morris K, Crowley K, Newman A. 2006. Analysis of amorphous and nanocrystalline solids from their X-ray diffraction patterns. Pharm Res 23:2333-2349.
51. Hancock BC, Shalaev EY, Shamblin SL. 2002. Polyamorphism: A pharmaceutical science perspective. J Pharm Pharmacol 54:1151-1152.
52. Rabinowitz JD, Lloyd PM, Munzar P, Myers DJ, Cross S, Damani R, Quintana R, Spyker DA, Soni P, Cassella JV. 2006. Ultra-fast absorption of amorphous pure drug aerosols via deep lung inhalation. J Pharm Sci 95:2438-2451.
53. Zografi G. 1988. States of water associated with solids. Drug Dev Ind Pharm 14:1905-1926.
54. Zografi G, Bryn SR. 1999. Effects of residual water on solid-state stability of drugs and drug products. In: Roos YH, Leslie RB, Lillford PJ, editors. Water management in the design and distribution of quality foods. Basel, Switzerland: ISPOW 7, Technomic Publishing Co, Inc. pp 397-410.
55. Zografi G, Hancock B. 1993. Chapter 28: Water-solid interactions in pharmaceutical systems. In: Crommelin DJA, Midha KK, Nagai T, editors. Topics in pharmaceutical sciences (FIP: International pharmaceutical federation). Stuttgart: Medpharm Scientific Publishers. pp 405-419.
56. Zografi G. 1981. Interactions at the Vapor-Solid Interface in Pharmaceutical Systems. Topics in Pharmaceutical Sciences North-Holland Biomedical Press:427-442.
57. Shalaev EY, Zografi G. 1996. How does residual water affect the solid-state degradation of drugs in the amorphous state? J Pharm Sci 85:1137-1141.
58. Hancock BC, Shamblin SL, Zografi G. 1995. The molecular mobility of amorphous pharmaceutical solids below their glass transition temperatures. Pharm Res 12:799-806.
59. Hancock BC, Zografi G. 1994. The relationship between the glass transition temperature and the water content of amorphous pharmaceutical solids. Pharm Res 11:471-477.
60. Ahlneck C, Zografi G. 1990. The molecular basis of moisture effects on the physical and chemical stability of drugs in the solid state. Int J Pharm 62:87-95.
61. Bryn SR, Xu W, Newman AW. 2001. Chemical reactivity in solid-state pharmaceuticals: Formulation implications. Adv Drug Deliv Rev 48:115-136.
62. Suryanarayanan R. 1995. X-ray powder diffractometry. In: Brittain HG, editors. Physical characterization of pharmaceutical solids. New York, NY: Marcel Dekker. pp 187-222.
63. Saleki-Gerhardt A, Ahlneck C, Zografi G. 1994. Assessment of disorder in crystalline solids. Int J Pharm 101:237-247.
64. Giron D, Edel B, Piechon P. 1990. X-ray quantitative determination of polymorphism in pharmaceuticals. Mol Crystals Liquid Crystals 187:297-307.
65. Stephenson GA, Forbes RA, Reutzel-Edens SM. 2001. Characterization of the solid state: Quantitative issues. Adv Drug Deliv Rev 48:67-90.
66. Clas S-D, Dalton CR, Hancock BC. 1999. Differential scanning calorimetry: Applications in drug development. Pharm Sci Technol Today 2:311-320.
67. Giron D. 1995. Thermal analysis and calorimetric methods in the characterisation of polymorphs and solvates. Thermochimica Acta 248:1-59.
68. Ford JL. 1989. Pharmaceutical thermal analysis, techniques and applications. Book/Ellis Horwood Limited, Halsted Press, A Division of John Wiley & Sons: NY, Chichester Brisbane Toronto.
69. McCauley JA, Brittain HG. 1995. Thermal methods of analysis. In: Brittain HG, editors. Physical characterization of pharmaceutical solids. New York, NY: Marcel Dekker. pp 223-252.
70. Buckton G, Russell SJ, Beezer AE. 1991. Pharmaceutical calorimetry - a selective review. Thermochimica Acta 193:195-214.
71. Gombas A, Szabo-Revesz P, Kata M, Regdon G, Jr., Eros I. 2002. Quantitative determination of crystallinity of alpha-lactose monohydrate by DSC. J Therm Anal Calorimetry 68:503-510.
72. Giron D, Remy P, Thomas S, Vilette E. 1997. Quantitation of amorphicity by microcalorimetry. J Therm Anal 48:465-472.
73. Fagegaltier N, Lamure A, Lacabanne C, Caron A, Mifsud H, Bauer M. 1997. Thermal analysis of amorphous phase in a pharmaceutical drug. J Therm Anal 48:459-464.
74. Buckton G. 1997. Characterization of small changes in the physical properties of powders of significance for dry powder inhaler formulations. Adv Drug Deliv Rev 26:17-27.
75. Pudipeddi M, Sokoloski TD, Duddu SP, Carstensen JT. 1996. Quantitative characterization of adsorption isotherms using isothermal microcalorimetry. J Pharm Sci 85:381-386.
76. Lechuga-Ballesteros D, Bakri A, Miller DP. 2003. Microcalorimetric measurement of the interactions between water vapor and amorphous pharmaceutical solids. Pharm Res 20:308-318.
77. Buckton G, Beezer AE. 1988. A microcalorimetric study of powder surface energetics. Int J Pharm 41:139-145.
78. Sheridan PL, Buckton G, Storey DE. 1995. Development of a flow microcalorimetry for the assesment of surface-properties of powders. Pharm Res 12:1025-1030.
79. Price R, Young PM. 2004. Visualization of the crystallization of lactose from the amorphous state. J Pharm Sci 93:155-164.
80. Price R, Young PM, Edge S, Staniforth JN. 2002. The influence of relative humidity on particulate interactions in carrier-based dry powder inhaler formulations. Int J Pharm 246:47-59.
81. Strickland WA, Jr. 1962. Study of water vapor sorption by pharmaceutical powders. J Pharm Sci 51:310-314.
82. Hancock BC, Shamblin SL. 1998. Water vapour sorption by pharmaceutical sugars. Pharm Sci Technol Today 1:345-351.
83. Garnier S, Petit S, Coquerel G. 2002. Dehydration mechanism and crystallisation behaviour of lactose. J Therm Anal Calorimetry 68:489-502.
84. Burnett DJ, Thielmann F, Sokoloski T, Brum J. 2006. Investigating the moisture-induced crystallization kinetics of spray-dried lactose. Int J Pharm 313:23-28.
85. Kontny MJ, Zografi G. 1995. Sorption of water by solids. In: Brittain HG, editors. Physical characterization of pharmaceutical solids. New York, NY: Marcel Dekker. pp 387-418.
86. Mansour HM, Zografi G. 2007. The relationship between water vapor absorption and desorption by phospholipids and bilayer phase transitions. J Pharm Sci 96:377-396.
87. Buckton G, Darcy P. 1999. Assessment of disorder in crystalline powders - a review of analytical techniques and their application. Int J Pharm 179:141-158.
88. Kontny MJ. 1988. Distribution of water in solid pharmaceutical systems. Drug Dev Ind Pharm 14:1991-2027.
89. Van Campen L, Zografi G, Carstensen JT. 1980. An approach to the evaluation of hygroscopicity for pharmaceutical solids. Int J Pharm 5:1-18.
90. Umprayn K, Mendes RW. 1987. Hygroscopicity and moisture adsorption kinetics of pharmaceutical solids: A review. Drug Dev Ind Pharm 13:653-693.
91. Hickey AJ, Martonen TB. 1993. Behavior of hygroscopic pharmaceutical aerosols and the influence of hydrophobic additives. Pharm Res 10:1-7.
92. Hickey AJ. 1993. Targeting of pharmaceutical aerosols to the lung: What can be learned from inhalation toxicology and industrial hygiene? Sci Technol 18:290-304.
93. Johnson DL, Wenger EN, Polikandritou-Lambros M. 1996. Aerosolization and hygroscopic growth evaluation of lyophilized liposome aerosols under controlled temperature and relative humidity conditions. Aerosol Sci Technol 25:22-30.
94. Peng CG, Chow AHL, Chan CK. 2000. Study of the hygroscopic properties of selected pharmaceutical aerosols using single particle levitation. Pharm Res 17:1104-1109.
95. Chan HK, Eberl S, Daviskas E, Constable C, Young I. 2002. Changes in lung deposition of aerosols due to hygroscopic growth: A fast SPECT study. J Aerosol Med Deposition Clearance Eff Lung 15:307-311.
96. Asgharian B. 2004. A model of deposition of hygroscopic particles in the human lung. Aerosol Sci Technol 38:938-947.
97. Forbes RT, Davis KG, Hindle M, Clarke JG, Maas J. 1998. Water vapor sorption studies on the physical stability of a series of spray-dried protein/sugar powders for inhalation. J Pharm Sci 87:1316-1321.
98. Naini V, Byron PR, Phillips EM. 1998. Physicochemical stability of crystalline sugars and their spray-dried forms: Dependence upon relative humidity and suitability for use in powder inhalers. Drug Dev Ind Pharm 24:895-909.
99. Bunker M, Davies M, Roberts C. 2005. Towards screening of inhalation formulations: Measuring interactions with atomic force microscopy. Expert Opin Drug Deliv 2:613-624.
100. Roberts CJ. 2005. What can we learn from atomic force microscopy adhesion measurements with single drug particles? Eur J Pharm Sci 24:153-157.
101. Jalili N, Laxminarayana K. 2004. A review of atomic force microscopy imaging systems: Application to molecular metrology and biological sciences. Mechatronics 14:907-945.
102. Dunbar C, Hickey AJ, Holzner P. 1998. Dispersion and characterization of pharmaceutical dry powder aerosols. KONA Powder Part 16:7-45.
103. Stewart P. 1981. Influence of magnesium searate on the homogeneity of a prednisone-granule ordered mix. Drug Dev Ind Pharm 7:485-495.
104. Okada J. 1969. Measurement of the adhesive force of pharmaceutical powders by centrifugal method. Yakugaku Zasshi 89:1539-1544.
105. Podczeck F, Newton JM. 1995. Development of an ultracentrifuge technique to determine the adhesion and friction properties between particles and surfaces. J Pharm Sci 84:1067-1071.
106. Podczech F, Newton JM, James MB. 1995. Assesment of adhesion and auto adhesion forces between particles and surfaces. II: The investigation of adhesion phenomena of salmeterol xinafoate and lactose monohydrate particles in particle-on-particle and particle-on-suface contact. J Adhes Sci Technol 9: 475-486.
107. Otsuka A. 1988. Measurement of the adhesive force between particles of powdered materials and a glass substrate by means of the impact separation method III. Effect of particle shape and surface asperity. Chem Pharm Bull (Tokyo) 36:741-749.
108. Iida K. 1993. Measurement of the adhesie force between particles and a substrate by means of the impact separation method. Effect of the surface roughness and type of material of the substrate. Chem Pharm Bull (Tokyo) 41:1621-1625.
109. Concessio NM, VanOort MM, Knowles MR, Hickey AJ. 1999. Pharmaceutical dry powder aerosols: Correlation of powder properties with dose delivery and implications for pharmacodynamic effect. Pharm Res 16:828-834.
110. Ducker WA. 1991. Direct measurement of colloidal forces using an atomic force microscope. Nature 353:239.
111. Ducker WA. 1992. Measurement of forces in liquids using a force microscope. Langmuir 8:1831-1836.
112. Podczek P. 1996. The adhesion force of micronized salmeterol xinafoate particles to pharmaceutically relevant surface materials. J Phys D 29:1878-1884.
113. Davies M, Brindley A, Chen X, Marlow M, Doughty SW, Shrubb I, Roberts CJ. 2005. Characterization of drug particle surface energetics and young's modulus by atomic force microscopy and inverse gas chromatography. Pharm Res 22:1158-1166.
114. Traini D, Rogueda P, Young P, Price R. 2005. Surface energy and interparticle forces correlation in model pMDI formulations. Pharm Res 22:816-825.
115. Begat P, Morton DA, Staniforth JN, Price R. 2004. The cohesive-adhesive balances in dry powder inhaler formulations I: Direct quantification by atomic force microscopy. Pharm Res 21:1591-1597.
116. Podczeck F. 1998. Evaluation of the adhesion properties of salbutamol sulphate to inhaler materials. Pharm Res 15:806-808.
117. Tsukada MR, Irie YY, Noda R, Kamiya H, Watanabe W, Kauppinen EI. 2004. Adhesion force measurement of a DPI size pharmaceutical particle by colloid probe atomic force microscopy. Powder Technol 141:262-269.
118. Heng PW, Chan LW, Lim LT. 2000. Quantification of the surface morphologies of lactose carriers and their effect on the in vitro deposition of salbutamol sulphate. Chem Pharm Bull (Tokyo) 48:393-398.
119. Eve JK, Patel N, Luk SY, Ebbens SJ, Roberts CJ. 2002. A study of single drug particle adhesion interactions using atomic force microscopy. Int J Pharm 238:17-27.
120. Beach ER, Tormoen GW, Drelich J, Han R. 2002. Pull-off force measurements between rough surfaces by atomic force microscopy. J Colloid Interface Sci 247:84-99.
121. Rabinovich YI, Adler JJ, Ata A, Singh RK, Moudgil BM. 2000. Adhesion between nanoscale rough surfaces. J Colloid Interface Sci 232:17-24.
122. Islam N, Stewart P, Larson I, Hartley P. 2005. Surface roughness contribution to the adhesion force distribution of salmeterol xinafoate on lactose carriers by atomic force microscopy. J Pharm Sci 94:1500-1511.
123. Zhou H, Götzinger W, Peukert W. 2003. The influence of particle charge and roughness on particle-substrate adhesion. Powder Technol 135-136:82-91.
124. Gotzinger M, Peukert W. 2004. Particle adhesion force distributions on rough surfaces. Langmuir 20:5298-5303.
125. Young PM, Price R. 2004. The influence of humidity on the aerosolisation of micronised and SEDS produced salbutamol sulphate. Eur J Pharm Sci 22:235-240.
126. Danesh A, Chen X, Davies MC, Roberts CJ, Sanders GH, Tendler SJ, Williams PM, Wilkins MJ. 2000. The discrimination of drug polymorphic forms from single crystals using atomic force microscopy. Pharm Res 17:887-890.
127. Young PM, Cocconi D, Colombo P, Bettini R, Price R, Steele DF, Tobyn MJ. 2002. Characterization of a surface modified dry powder inhalation carrier prepared by "particle smoothing". J Pharm Pharmacol 54:1339-1344.
128. Hooton JC, German CS, Allen S, Davies MC, Roberts CJ, Tendler SJ, Williams PM. 2004. An atomic force microscopy study of the effect of nanoscale contact geometry and surface chemistry on the adhesion of pharmaceutical particles. Pharm Res 21:953-961.
129. Zhang J, Ebbens S, Chen X, Jin Z, Luk S, Madden C, Patel N, Roberts CJ. 2006. Determination of the surface free energy of crystalline and amorphous lactose by atomic force microscopy adhesion measurement. Pharm Res 23:401-407.
130. Berard V, Lesniewska E, Andres C, Pertuy D, Laroche C, Pourcelot Y. 2002. Affinity scale between a carrier and a drug in DPI studied by atomic force microscopy. Int J Pharm 247:127-137.
131. Price R, Young PM. 2005. On the physical transformations of processed pharmaceutical solids. Micron 36:519-524.
132. Hooton JC, German CS, Davies MC, Roberts CJ. 2006. A comparison of morphology and surface energy characteristics of sulfathiazole polymorphs based upon single particle studies. Eur J Pharm Sci 28:315-324.
133. Jonhnson KL, Kendall K, Roberts AD. 1971. Surface energy and contact of elastic solids. Proc R Soc London, Ser 324:301.
134. Ward S, Perkins M, Zhang J, Roberts CJ, Madden CE, Luk SY, Patel N, Ebbens SJ. 2005. Identifying and mapping surface amorphous domains. Pharm Res 22:1195-1202.
135. Willing GA, Ibrahim TH, Etzler FM, Neuman RD. 2000. New approach to the study of particle-surface adhesion using atomic force microscopy. J Colloid Interface Sci 226:185-188.
136. Sindel U, Zimmermann I. 2001. Measurement of interaction forces between individual powder particles using atomic force microscope. Powder Technol 117:559-567.
137. Traini D, Young PM, Jones M, Edge S, Price R. 2006. Comparative study of erythritol and lactose monohydrate as carriers for inhalation: Atomic force microscopy and in vitro correlation. Eur J Pharm Sci 27:243-251.
138. Staniforth JN, Rees JE, Lai FK, Hersey JA. 1982. Interparticle forces in binary and ternary ordered powder mixes. J Pharm Pharmacol 34:141-145.
139. Louey MD, Stewart PJ. 2002. Particle interactions involved in aerosol dispersion of ternary interactive mixtures. Pharm Res 19:1524-1531.
140. Begat P, Price R, Harris H, Morton DAV, Staniforth JN. 2005. The influence of force control agents on the cohesive-adhesive balance in dry powder inhaler formulations. KONA 23:109-121.
141. Begat P, Morton DA, Staniforth JN, Price R. 2004. The cohesive-adhesive balances in dry powder inhaler formulations II: Influence on fine particle delivery characteristics. Pharm Res 21:1826-1833.
142. Ashayer R, Luckham PF, Manimaaran S, Rogueda P. 2004. Investigation of the molecular interactions in a pMDI formulation by atomic force microscopy. Eur J Pharm Sci 21:533-543.
143. Young PM, Price R, Lewis D, Edge S, Traini D. 2003. Under pressure: Predicting pressurized metered dose inhaler interactions using the atomic force microscope. J Colloid Interface Sci 262:298-302.
144. Young PM, Price R, Tobyn MJ, Buttrum M, Dey F. 2004. The influence of relative humidity on the cohesion properties of micronized drugs used in inhalation therapy. J Pharm Sci 93:753-761.
145. Berard V, Lesniewska E, Andres C, Pertuy D, Laroche C, Pourcelot Y. 2002. Dry powder inhaler: Influence of humidity on topology and adhesion studied by AFM. Int J Pharm 232:213-224.
146. Dey FK. 2000. Atomic force microscopy study of absorbed moisture on lactose particles. Adv Powder Technol 11:401-413.
147. Louey MD, Mulvaney P, Stewart PJ. 2001. Characterisation of adhesional properties of lactose carriers using atomic force microscopy. J Pharm Biomed Anal 25:559-567.
148. Hooton JC, German CS, Allen S, Davies MC, Roberts CJ, Tendler SJ, Williams P. 2003. Characterization of particle-interactions by atomic force microscopy: Effect of contact area. Pharm Res 20:508-514.
149. Mukhopadhyay P, Schreiber HP. 1994. Aspects of polymer surface characterization by inverse gas-chromatography. J Polym Sci Pol Phys 32:1653-1656.
150. Osmont E, Schreiber HP. 1989. Surface characteristics of glass fibres. In: Lloyd DR, Ward TC, Schreiber HP, editors. Inverse gas chromatography: Characterization of polymers and other materials. Washington, DC: American Chemical Society. pp 230-247.
151. Schultz J, Lavielle L, Martin C. 1987. The role of the interface in carbon fibre-epoxy composites. J Adhesion 23:45-60.
152. Cline D, Dalby R. 2002. Predicting the quality of powders for inhalation from surface energy and area. Pharm Res 19:1274-1277.
153. Sethuraman VV, Hickey AJ. 2002. Powder properties and their influence on dry powder inhaler delivery of an antitubercular drug. AAPS Pharm Sci Tech 3:E28.
154. Columbano A, Buckton G, Wikeley P. 2003. Characterisation of surface modified salbutamol sulphate-alkylpolyglycoside microparticles prepared by spray drying. Int J Pharm 253:61-70.
155. Traini D, Rogueda P, Young P, Price R. 2005. Surface energy and interparticle forces correlations in model pMDI formulations. Pharm Res 22:816-825.
156. Sun CH, Berg JC. 2003. A review of the different techniques for solid surface acid-base characterization. Adv Colloid Interface 105:151-175.
157. Fowkes FM. 1964. Attractive forces at interfaces. Ind Eng Chem 56:40-52.
158. Fowkes FM. 1962. Determination of interfacial tensions, contact angles, and dispersion forces in surfaces by assuming additivity of intermolecular interactions in surfaces. J Phys Chem-Us 66:382.
159. Katz S, Gray DG. 1981. The adsorption of hydrocarbons on cellophane. 1. Zero coverage limit. J Colloid Interface Sci 82:318-325.
160. Dorris GM, Gray DG. 1980. Adsorption of normal-alkanes at zero surface coverage on cellulose paper and wood fibers. J Colloid Interf Sci 77:353-362.
161. Gutmann V. 1978. The donor-acceptor approach to molecular interactions. New York: Plenum Press.
162. Riddle FL, Fowkes FM. 1990. Spectral shifts in acid-base chemistry. 1. Vanderwaals contributions to acceptor numbers. J Am Chem Soc 112:3259-3264.
163. Ticehurst MD, Rowe RC, York P. 1994. Determination of the surface properties of two batches of salbutamol sulphate by inverse gas chromatography. Int J Pharm 111:241-249.
164. Feeley JC, York P, Sumby BS, Dicks H. 1998. Determination of surface properties and how characteristics of salbutamol sulphate, before and after micronisation. Int J Pharm 172:89-96.
165. Grimsey IM, Feeley JC, York P. 2002. Analysis of the surface energy of pharmaceutical powders by inverse gas chromatography. J Pharm Sci 91:571-583.
166. Ohta M, Buckton G. 2004. The use of inverse gas chromatography to assess the acid-base contributions to surface energies of cefditoren pivoxil and methacrylate copolymers and possible links to instability. Int J Pharm 272:121-128.
167. Ohta M, Buckton G. 2004. Determination of the changes in surface energetics of cefditoren pivoxil as a consequence of processing induced disorder and equilibration to different relative humidities. Int J Pharm 269:81-88.
168. Ohta M, Buckton G. 2005. A study of the differences between two amorphous spray-dried samples of cefditoren pivoxil which exhibited different physical stabilities. Int J Pharm 289: 31-38.
169. Planinsek O, Buckton G. 2003. Inverse gas chromatography: Considerations about appropriate use for amorphous and crystalline powders. J Pharm Sci 92:1286-1294.
170. Planinsek O, Zadnik J, Rozman S, Kunaver M, Dreu R, Srcic S. 2003. Influence of inverse gas chromatography measurement conditions on surface energy parameters of lactose monohydrate. Int J Pharm 256:17-23.
171. Traini D, Rogueda P, Young P, Price R. 2005. Surface energy and interparticle forces correlations in model pMDI formulations. Pharm Res 22:816-825.
172. Telko MJ, Hickey AJ. 2007. Critical assessment of inverse gas chromatography as means of assessing surface free energy and acid-base interaction of pharmaceutical powders. J Pharm Sci (in press).
173. Conder JR, Young CL. 1979. Physicochemical measurement by gas chromatography. Chichester; New York: Wiley: p xix, 632.
174. Lide DR, Kehiaian HV. 1994. CRC handbook of thermophysical and thermochemical data. Boca Raton: CRC Press: p x, 518.
175. Lerk CF, Andreae AC, de Boer AH, de Hoog P, Kussindrager K, van Leverink J. 1984. Alterations of alpha-lactose during differential scanning calorimetry. J Pharm Sci 73:856-857.
176. Young PM, Tobyn MJ, Price R, Buttrum M, Dey F. 2006. The use of colloid probe microscopy to predict aerosolization performance in dry powder inhalers: AFM and in vitro correlation. J Pharm Sci 95:1800-1809.
177. Hooton JC, Jones MD, Price R. 2006. Predicting the behavior of novel sugar carriers for dry powder inhaler formulations via the use of a cohesive-adhesive force balance approach. J Pharm Sci 95:1288-1297.
178. Park SJ, Brendle M. 1997. London dispersive component of the surface free energy and surface enthalpy. J Colloid Interface Sci 188:336-339.